| P2093 | author name string | Arul M Chinnaiyan | |
| | David L Rimm | |
| | Mark A Rubin | |
| | Matthias D Hofer | |
| | Rainer Kuefer | |
| | Maciej P Zerkowski | |
| | Robert L Camp | |
| P2860 | cites work | alpha-Methylacyl-CoA racemase: expression levels of this novel cancer biomarker depend on tumor differentiation | Q24669748 |
| | The polycomb group protein EZH2 is involved in progression of prostate cancer | Q29614514 |
| | Delineation of prognostic biomarkers in prostate cancer | Q29617971 |
| | P504S: a new molecular marker for the detection of prostate carcinoma | Q30758020 |
| | Analysis of microarray data using Z score transformation | Q30787499 |
| | Alpha-Methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions | Q30837945 |
| | Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. | Q30854592 |
| | alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer | Q34121458 |
| | Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer. | Q34123931 |
| | Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone | Q34188159 |
| | Expression and diagnostic utility of alpha-methylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer | Q34199847 |
| | Real-world performance of HER2 testing--National Surgical Adjuvant Breast and Bowel Project experience | Q34669824 |
| | Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centres. | Q38453048 |
| | Low p27 expression predicts poor disease-free survival in patients with prostate cancer | Q38472792 |
| | Expression of alpha-Methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate | Q42523961 |
| | Prostatic foamy gland carcinoma with aggressive behavior: clinicopathologic, immunohistochemical, and ultrastructural analysis. | Q50505540 |
| | Automated subcellular localization and quantification of protein expression in tissue microarrays. | Q52030096 |
| | E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology. | Q53999986 |
| | Prostatic carcinoma with abundant xanthomatous cytoplasm. Foamy gland carcinoma | Q71009409 |
| | Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcome | Q73205060 |
| | Rapid ("warm") autopsy study for procurement of metastatic prostate cancer | Q73605064 |
| | Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade | Q77553785 |
| | Expression of p27/Kip1 is down-regulated in human prostate carcinoma progression | Q77976585 |
| | Sequence variants of alpha-methylacyl-CoA racemase are associated with prostate cancer risk | Q78532762 |
| | P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies | Q78595075 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | automation | Q184199 |
| | biomarker | Q864574 |
| | prostate cancer | Q181257 |
| P304 | page(s) | 831-40 | |
| P577 | publication date | 2004-03-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Quantitative determination of expression of the prostate cancer protein alpha-methylacyl-CoA racemase using automated quantitative analysis (AQUA): a novel paradigm for automated and continuous biomarker measurements | |
| P478 | volume | 164 | |